Related Experiment Videos
Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC)
F M MacKenzie1, M J Struelens, K J Towner
1Medical Microbiology, Aberdeen Royal Infirmary, Aberdeen, UK. f.m.mackenzie@abdn.ac.uk
Summary
Antimicrobial resistance (AMR) poses a significant public health challenge in Europe, with varying prevalence and control methods. The ARPAC project established recommendations for evidence-based practices to combat AMR in European hospitals.
Area of Science:
- Public Health
- Infectious Diseases
- Clinical Microbiology
Background:
- Antimicrobial resistance (AMR) is a critical public health issue in Europe.
- Significant geographical variations exist in AMR prevalence and control strategies across the continent.
Framework:
- The 'Antibiotic Resistance; Prevention and Control (ARPAC)' project, funded by the European Commission and led by ESCMID study groups.
- Established a European hospital network to gather data on AMR prevalence, susceptibility testing, antimicrobial use, and policies.
Implementation:
- The ARPAC Consensus Conference in Amsterdam (November 2004) convened experts to discuss findings.
- Co-hosted by the European Commission, ESCMID, and SWAB, focusing on evidence-based practices for AMR control.
Implications:
- The conference generated high-priority recommendations to significantly impact AMR control in European hospitals.
- Aimed to inform future evidence-based practices for managing antimicrobial resistance.
- The report summarizes key recommendations for combating AMR.